Literature DB >> 28828039

Complete genome sequence of Peptoclostridium difficile strain Z31.

Francisco C F Lobato1, Henrique C P Figueiredo2,3, Felipe L Pereira2, Carlos A Oliveira Júnior1, Rodrigo O S Silva1, Fernanda A Dorella2, Alex F Carvalho2, Gabriel M F Almeida2, Carlos A G Leal2.   

Abstract

BACKGROUND: Peptoclostridium (Clostridium) difficile is a spore-forming bacterium responsible for nosocomial infections in humans. It is recognized as an important agent of diarrhea and colitis in several animal species and a possible zoonotic agent. Despite the known importance of P. difficile infection in humans and animals, no vaccine or other effective measure to control the disease is commercially available. A possible alternative treatment for P. difficile infection is the use of a nontoxigenic strain of P. difficile as a competitive exclusion agent. However, a thorough knowledge of this strain is necessary for this purpose. We selected P. difficile Z31, a nontoxigenic strain (PCR ribotype 009), for investigation because it prevents P. difficile infection in a hamster model.
RESULTS: The genome sequence of P. difficile Z31 is a circular chromosome of 4298,263 bp, with a 29.21 % GC content, encoding 4128 proteins, and containing 78 pseudogenes. This strain belongs to ST 3, clade 1, and has five phage regions in its genome. Genes responsible for resistance to tetracycline and erythromycin were detected and more importantly, Z31 also contains genes that promote spore production and stability, cell attachment, intestinal adherence, and biofilm formation.
CONCLUSION: In this study, we present the first complete genome sequence of nontoxigenic P. difficile strain Z31. When the Z31 genome was compared with those of other isolates available in GenBank, including a draft genome of a nontoxigenic strain, several unique regions were evident. Z31 contains no toxin genes, but encodes several non-toxin virulence factors, which may favor host colonization.

Entities:  

Keywords:  Competitive exclusion; Genome sequencing; Live vaccine; Peptoclostridium (Clostridium) difficile

Year:  2016        PMID: 28828039      PMCID: PMC5562067          DOI: 10.1186/s13099-016-0095-3

Source DB:  PubMed          Journal:  Gut Pathog        ISSN: 1757-4749            Impact factor:   4.181


Background

Peptoclostridium difficile, initially called Bacillus difficilis, was first isolated from the meconium of newborns by Hall and O’Toole in 1935 [1]. The name ‘Clostridium difficile’ was made official in 1980 in the Approved Lists of Bacterial Names [2] based on a phenotypic study by Prevót [3]. Recently, in a study based on 16S rRNA and ribosomal protein sequences, Yutin and Galperin [4] proposed the reallocation of some Clostridium species into six new genera, renaming C. difficilePeptoclostridium difficile’. The genus Peptoclostridium, in the phylum Firmicutes, class Clostridia, order Clostridiales, and family Peptostreptococcaceae [4], is characterized by strictly anaerobic, motile, pleomorphic Gram-positive bacteria, with dimensions of 0.5–1.9 × 3.0–16.9 µm, which form oval subterminal spores (Fig. 1) with a bacillus cell shape. The bacteria are spore-forming and mesophilic (20–37 °C), with an optimal pH range of neutral to alkaline. They ferment fructose, glucose, levulose, mannitol, mannose, salicin, and usually xylose, but not galactose, glycerol, inulin, lactose, raffinose, or sucrose. They are chemoorganotrophs and can use yeast extract as their sole carbon and energy source and peptone as their nitrogen source. Peptoclostridium difficile liquefies gelatin, but does not attack coagulated serum, milk, or meat proteins and is unable to reduce sulfate. It is negative for lecithinase, lipase, oxidase, and catalase. Acetate is produced as a major end product, but it also produces butyrate, formate, isobutyrate, isocaproate, isovalerate, lactate, and valerate [3-5].
Fig. 1

Photomicrograph of Peptoclostridium difficile strain Z31

Photomicrograph of Peptoclostridium difficile strain Z31 Until the late 1970s, P. difficile was not recognized as pathogenic bacteria. However, in this decade, P. difficile and its toxins were related in fecal contents of human patients with pseudomembranous colitis [6] and the disease was reproduced in hamsters [7], confirming the importance of this microorganism as an enteropathogen. Today, this bacterium is known to be the cause of P. difficile infection (PDI), the main cause of nosocomial diarrhea in humans worldwide and a possible cause of diarrhea in general community [8, 9]. In veterinary medicine, P. difficile is the most important uncontrolled cause of neonatal diarrhea in piglets in the USA and Europe, and also occurs in other domestic animals and some wild species [10, 11]. In piglets, CDI affects animals to 1–7 days of life, and it was demonstrated that until 1 day of life, 68–100 % of the animals are infected by the microorganism [12, 13]. The disease is subclinical, and just few animals show diarrhea, however, the infection can affect the development of the animals causing economic losses to the farmer [14]. The pathogeny of PDI involves the colonization of colon by some toxigenic strain of P. difficile and production of its toxins, the toxin A, an enterotoxin, and toxin B, a cytotoxin, that act synergistically causing cytoskeleton damages, cell rounding, disruption of tight junctions and cell death [15]. The genes responsible to produce toxins, the main difference between toxigenic and nontoxigenic strains, are localized in a pathogenicity locus of 19 kb, called PaLoc [16]. Despite the known importance of P. difficile in humans and animals, no vaccine is yet commercially available. Studies have shown that recombinant and classical immunogens expressing toxins A and B can prevent the occurrence of diarrhea or reduce the severity of P. difficile infection (PDI) in a rodent model [17]. These vaccines might limit, but cannot prevent, the fecal shedding of the microorganism, which is essential because P. difficile is a nosocomial pathogen. Because this bacterium is also a potential zoonotic agent, preventing its colonization of domestic animals should be a priority [10]. Among other alternative preventive strategies examined, the use of nontoxigenic P. difficile strains to prevent PDI has been shown to reduce the occurrence of the disease in humans and piglets by preventing their colonization by toxigenic strains [18-21]. There has been no report of the complete genome sequence of a nontoxigenic P. difficile strain, a necessary step in understanding this candidate live vaccine. Therefore, in this study, we determined the complete genome sequence of P. difficile nontoxigenic strain Z31.

Methods

Growth conditions and DNA isolation

Peptoclostridium difficile Z31, ribotype 009, a nontoxigenic strain isolated from a healthy dog on February 1, 2009, in the city of Belo Horizonte (state of Minas Gerais, Brazil), was selected for sequencing because it prevented PDI in hamster model [22], similar to some strains previously reported [23]. This strain was grown in Mueller–Hinton agar supplemented with 5 % blood and 0.1 % taurocholate at 37 °C under anaerobic conditions for 48–72 h. Its genomic DNA was extracted with the Maxwell 16® Research Instrument (Promega, USA) combined with lysozyme (10 mg/mL) and proteinase K (20 mg/mL). Briefly, cells were incubated overnight in lysozyme solution (10 mg/mL) at 37 °C. Proteinase K was added and the mixture was incubated at 56 °C for 30 min. According to the kit instructions: (i) the samples were lysed in the presence of a chaotropic agent and a detergent; (ii) the nucleic acids were bound to silica magnetic particles; (iii) the bound particles were washed, to isolate them from other cell components; and (iv) the nucleic acids were eluted into a formulation for sequencing. The extracted DNA was stored at −80 °C until analysis.

Genome sequencing and assembly

The genome was sequenced with the Ion Torrent PGM™, in a mate-pair sequencing kit with an insert size of 3 kbp (~144-fold coverage) and with a fragment sequencing 400 bp kit (~318-fold coverage). The quality of the raw data was analyzed with FastQC [24] and the sequence was assembled with the Mira 4.9.1 software [25] and Newbler 2.9 (Roche, USA) for the fragment library, and with SPAdes 3.5.0 [26] for the mate-pair library (the parameters for all the assembler software are shown in Additional file 1). This was the ab initio strategy applied to all libraries. The larges contigs obtained with Newbler and Mira were used as input, as trusted-contigs, in SPAdes. We obtained 20 scaffolds, with an N50 value of 698,574 bp, and the largest scaffold had a length size of 1691,449 bp. Gap filling was conducted with CLC Genomics Workbench 7 (Qiagen, USA), after the construction of a super scaffold with the CONTIGuator 2.0 software [27], using the default parameters and P. difficile strain CD196 (GenBank: NC_013315.1) as the reference. The gaps in the rRNA operon regions were filled by consensus mapping to the reference, and the remaining gaps were mapped recursively to the raw data on the gap flanks, and it was repeated several times until an overlap was found.

Genome annotation

The genome was annotated automatically with the Prokka 1.10 software (Rapid Bacterial Genome Annotation) [28], with the default parameters and nested databases in the order: TrEMBL Uniprot containing only (Pepto) Clostridium spp. proteins and RefSeq database. The genome was also curated manually in all putative frameshifts using the Artemis software [29], based on the coverage visualized with the CLC Genomics Workbench 7 software, with corrected indel assembly bias. Genes encoding signal peptides were identified with the SignalP 4.0 software [30] on a local installation, followed by the identification of transmembrane helices with Tmhmm 2.0 [31] and a Pfam domain search with PfamScan [32]. These three tools were used with their default parameters.

Multilocus sequence typing (MLST) and in silico PCR

MLST was performed with PubMLST (available at http://pubmlst.org/cdifficile/) using the complete genome sequence. An in silico PCR search for genes related to virulence factors and antimicrobial resistance was performed with the jPCR software [33], with the default parameters and the primer sets shown in Additional file 2.

Quality assurance

Genomic DNA was isolated from a pure bacterial isolate and confirmed with 16S rRNA gene sequencing. All the raw sequencing data were mapped onto the final genome and the lack of contamination with other genomes was confirmed by the coverage and the low number of unmapped reads. An alignment was constructed with the 16S rRNA sequence regions on the assembled scaffolds, predicted with the Barrnap software (available at https://github.com/tseemann/barrnap), and the 16S rRNA genes of genomes available in GenBank. A phylogenetic tree was constructed from this alignment with the neighbor-joining method based on 1000 randomly selected bootstrap replicates, using the CLC Genomic Workbench 7.0 software. On the tree, strain Z31 was positioned among other P. difficile strains (Fig. 2).
Fig. 2

Phylogenetic tree of Peptoclostridium difficile strain Z31 representing the relative position in the genus Peptoclostridium based on 16S sequences. The statistical method used was maximum likelihood and the bootstrap number was 1000. Thus, the values next to the nodes represent the percentage on the number of times, in 1000 repetitions, in which that clade was formed

Phylogenetic tree of Peptoclostridium difficile strain Z31 representing the relative position in the genus Peptoclostridium based on 16S sequences. The statistical method used was maximum likelihood and the bootstrap number was 1000. Thus, the values next to the nodes represent the percentage on the number of times, in 1000 repetitions, in which that clade was formed

Results and discussion

After the genome assembly, gap filling, and annotation process, an in silico PCR was performed through searching for genes related to virulence factor, antibiotic resistance, and other known toxins. Considering the perspective of using the nontoxigenic strain Z31 to prevent PDI by competitive exclusion, some non-toxin virulence factors are desirable, predominantly those factors responsible for spore production and stability and those that promote cell attachment and host colonization. Z31 is positive for Cwp84 and surface-layer protein A (SlpA). SlpA is considered the major factor responsible for bacterial intestinal adherence, and Cwp84 is essential for the formation of that protein [34, 35]. GroEL, Cwp66, and a fibronectin-binding protein (Fbp68), which are also important in host-cell adherence, were also found [34-38]. Strain Z31 was also positive for genes encoding the flagellar proteins FliC and FliD, which play roles in the colonization and adherence of Z31 in vivo and are essential in later stages of biofilm formation [39-41]. These factors found in Z31 related to cell attachment are extremely important, because non toxigenic strains have to be able to compete with toxigenic strains by the colonization sites to prevent the disease [23]. The gene encoding the major regulator of sporulation in P. difficile, Spo0A, was detected in this strain. An absence or deficiency of Spo0A can cripple or impair the sporulation process [35, 42]. Genes encoding five spore coat proteins (cotA, cotB, cotC, cotD, and sodA) were also detected. The cotA protein is the most important protein in stabilizing the spore coat and ensures the integrity of this structure [43]. The formation of stable spores is also important for a nontoxigenic strain candidate to prevent the disease, because the bacteria need to pass through the stomach and be able to colonize the colon [23]. Vegetative cells are sensible to low pH, on the other hand, the spores resist to this conditions, allowing a great number of viable particles reaches the colon [44]. Genes responsible for resistance to tetracycline (tetM) and erythromycin (ermG) were also detected with previously described PCR primers [45, 46]. In contrast, none of the genes encoding proteins directly linked to toxin production were detected (tcdA, tcdB, tcdC, cdtA, or cdtB) [47] confirming the absence of the pathogenicity locus (PaLoc), which is essential for P. difficile infection [48]. Furthermore, the complete genomes of this species available at GenBank were selected to perform a similarity analysis with Gegenees software [49] with sequence fragmentation length of 500 nucleotides and a threshold of 30 %. Also, two complete genomes of species of the Clostridium genus were included as an outgroup. The similarity matrix was used to generate a heatplot and a “.nexus” format for phylogenomic analysis (Additional file 3). Although the Z31 strain is a nontoxigenic strain, the Additional file 3 shows that clade of this strain is paraphyletic with the type strain ATCC9689, a known as toxigenic strain, suggesting an evolutionary derivation of a same organism. Thereby, the nontoxigenic behavior of the Z31 strain seems to be occasioned by the losses of the toxin genes.

Initial findings

The P. difficile genome is composed of a circular chromosome of 4298,263 bp. The GC content is 29.21 % and the genome contains 78 pseudogenes. Briefly, the genome has 4206 CDSs, and encodes 29 rRNAs, one transfer–messenger RNA (tmRNA), and 58 tRNAs. Table 1 summarizes the subset of the 3809 genes with predicted functions that are associated with each COG functional categories. In summary, 3324 genes were predicted to have Pfam domains, 166 to have signal peptides, and 1011 to have transmembrane helices. No CRISPR repeats were found. Figure 3 shows the disposition of RNAs and CDSs coding sequences on the forward and reverse strands, the GC content, and the GC skew.
Table 1

Number of genes associated with general COG functional categories [55]

CodeValueb %agea Description
J2385.6585Translation, ribosomal structure and biogenesis
A00RNA processing and modification
K47911.3884Transcription
L1844.3747Replication, recombination and repair
B10.0237Chromatin structure and dynamics
D681.6167Cell cycle control, cell division, chromosome partitioning
V1343.1859Defense mechanisms
T3277.7746Signal transduction mechanisms
M2084.9453Cell wall/membrane biogenesis
N791.8782Cell motility
U400.9510Intracellular trafficking and secretion
O1112.6390Posttranslational modification, protein turnover, chaperones
C2195.2068Energy production and conversion
G3107.3704Carbohydrate transport and metabolism
E3217.6319Amino acid transport and metabolism
F932.2111Nucleotide transport and metabolism
H1473.4950Coenzyme transport and metabolism
I892.1160Lipid transport and metabolism
P1683.9942Inorganic ion transport and metabolism
Q571.3552Secondary metabolites biosynthesis, transport and catabolism
R3458.2025General function prediction only
S2515.9676Function unknown
20.0475Not in COGs

aThe percentage is based on the total number of protein coding genes in the annotated genome

bThe total not correspond to the final quantity of CDSs for each genome, because some genes are associated with more than one COG functional categories

Fig. 3

Graphical circular map of Peptoclostridium difficile strain Z31 genome. From outside to the center: predicted phage regions by PHAST; RNAs; CDSs on reverse strand; CDSs on forward strand; Blastn hits with BI9, BJ08, ATCC9689/DSM1296, BI1, 2007855, M120, CF5, CD196, CD630DERM, CD630, Cd5.3 strains; GC skew; and, GC content

Number of genes associated with general COG functional categories [55] aThe percentage is based on the total number of protein coding genes in the annotated genome bThe total not correspond to the final quantity of CDSs for each genome, because some genes are associated with more than one COG functional categories Graphical circular map of Peptoclostridium difficile strain Z31 genome. From outside to the center: predicted phage regions by PHAST; RNAs; CDSs on reverse strand; CDSs on forward strand; Blastn hits with BI9, BJ08, ATCC9689/DSM1296, BI1, 2007855, M120, CF5, CD196, CD630DERM, CD630, Cd5.3 strains; GC skew; and, GC content When the genome of Z31 was compared with those of other P. difficile strains deposited in GenBank [50], it showed high similarity to them (95.50 ± 2.68 %—Additional file 3), with the exception of some genomic islands (Fig. 3), four of which were predicted with PHAST [51] to be phage regions. A brief description of these phages is given in Table 2.
Table 2

Phage summary predicted by PHAST

NumberLength (kbp)CompletenessFirst common nameKeywordGC content
Phage 196.3IntactClostr_phi_CD119Integrase, terminase, portal, head, capsid, tail, lysin, plate, and protease28.9
Phage 224.1IncompleteClostr_phi_CD119Tail, lysin, and plate27.9
Phage 363.6IntactClostr_phiC2Integrase, terminase, portal, head, capsid, tail, and lysin28.6
Phage 4138.1IntactBacill_GProtease, recombinase, tail, transposase, integrase, head, capsid, portal, and terminase35.7
Phage summary predicted by PHAST A robust high-throughput MLST scheme for P. difficile was developed and validated [52], and allowed this species to be genotyped directly. Z31 was typed with MLST at loci adk 1, atpA 1, dxr 2, glyA 1, recA 1, sodA 1, and tpi 1, which classified this strain as ST3 in MLST clade 1. This result corroborates previous work, which reported that strains from PCR ribotype 009 are commonly classified as ST3 [53]. Strain Z31, P. difficile ATCC9689/DSM1296, and P. difficile BI9 were the only three ST3 strains identified among the strains whose complete genomes or near-complete genomes (e.g., one scaffold) are deposited in GenBank. However, Z31 contain some unique regions, as shown in Fig. 3 (U1–U12). In contrast, P. difficile 5.3, described as nontoxigenic by Darling et al. [54], belongs to ST15, clade 1, a common classification for strains of PCR ribotype 010.

Future directions

Further analysis of the P. difficile Z31 genome will provide new information about the adaptation of this strain to the gastrointestinal tract, and new insights into its inhibition of toxigenic P. difficile strains.

Availability of supporting data

This whole-genome shotgun sequence has been deposited in the DDBJ/EMBL/GenBank databases under accession number CP013196. The version described in this paper is the first version CP013196.1. Additional file 1. Assembler software (Mira, Newbler and SPAdes) parameters. Additional file 2. Primer sets used on in silico PCR for genes related to virulence factor, antibiotic resistance, and other known toxins. Additional file 3. Phylogenomic analysis performed using Gegenees.
  48 in total

1.  Clostridium difficile infection: a review of the literature.

Authors:  Fahmi Yousef Khan; Abdul-Naser Elzouki
Journal:  Asian Pac J Trop Med       Date:  2014-09       Impact factor: 1.226

2.  A genomic update on clostridial phylogeny: Gram-negative spore formers and other misplaced clostridia.

Authors:  Natalya Yutin; Michael Y Galperin
Journal:  Environ Microbiol       Date:  2013-07-09       Impact factor: 5.491

3.  A hidden Markov model for predicting transmembrane helices in protein sequences.

Authors:  E L Sonnhammer; G von Heijne; A Krogh
Journal:  Proc Int Conf Intell Syst Mol Biol       Date:  1998

4.  Functional characterization of Clostridium difficile spore coat proteins.

Authors:  Patima Permpoonpattana; Jutarop Phetcharaburanin; Anna Mikelsone; Marcin Dembek; Sisareuth Tan; Marie-Clémence Brisson; Roberto La Ragione; Alain R Brisson; Neil Fairweather; Huynh A Hong; Simon M Cutting
Journal:  J Bacteriol       Date:  2013-01-18       Impact factor: 3.490

5.  Acquisition of Clostridium difficile by piglets.

Authors:  N E M Hopman; E C Keessen; C Harmanus; I M J G Sanders; L A M G van Leengoed; E J Kuijper; L J A Lipman
Journal:  Vet Microbiol       Date:  2010-11-04       Impact factor: 3.293

6.  Manganese binds to Clostridium difficile Fbp68 and is essential for fibronectin binding.

Authors:  Yi-Pin Lin; Chih-Jung Kuo; Xhelil Koleci; Sean P McDonough; Yung-Fu Chang
Journal:  J Biol Chem       Date:  2010-11-09       Impact factor: 5.157

7.  The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives.

Authors:  Glen P Carter; Julian I Rood; Dena Lyras
Journal:  Gut Microbes       Date:  2010-01

8.  Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea?

Authors:  Robin L P Jump; Michael J Pultz; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

9.  Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile.

Authors:  Kristin J Nagaro; S Tyler Phillips; Adam K Cheknis; Susan P Sambol; Walter E Zukowski; Stuart Johnson; Dale N Gerding
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

10.  PHAST: a fast phage search tool.

Authors:  You Zhou; Yongjie Liang; Karlene H Lynch; Jonathan J Dennis; David S Wishart
Journal:  Nucleic Acids Res       Date:  2011-06-14       Impact factor: 16.971

View more
  5 in total

1.  Evaluation of growth and sporulation of a non-toxigenic strain of Clostridioides difficile (Z31) and its shelf viability.

Authors:  Carlos Augusto Oliveira Júnior; Rodrigo Otávio Silveira Silva; Diogo Soares Gonçalves Cruz; Isadora Honorato Pires; Guilherme Guerra Alves; Francisco Carlos Faria Lobato
Journal:  Braz J Microbiol       Date:  2018-12-18       Impact factor: 2.476

2.  Patterns of the fecal microbiota in the Juan Fernández fur seal (Arctocephalus philippii).

Authors:  Constanza Toro-Valdivieso; Frederick Toro; Samuel Stubbs; Eduardo Castro-Nallar; Barbara Blacklaws
Journal:  Microbiologyopen       Date:  2021-08       Impact factor: 3.139

Review 3.  Clostridioides difficile phage biology and application.

Authors:  Joshua Heuler; Louis-Charles Fortier; Xingmin Sun
Journal:  FEMS Microbiol Rev       Date:  2021-09-08       Impact factor: 16.408

4.  Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection.

Authors:  Xingmin Sun; Shaohui Wang; Joshua Heuler; Ishani Wickramage
Journal:  Microbiol Spectr       Date:  2022-03-22

5.  Comparative genomic analysis of Clostridium difficile ribotype 027 strains including the newly sequenced strain NCKUH-21 isolated from a patient in Taiwan.

Authors:  Haruo Suzuki; Masaru Tomita; Pei-Jane Tsai; Wen-Chien Ko; Yuan-Pin Hung; I-Hsiu Huang; Jenn-Wei Chen
Journal:  Gut Pathog       Date:  2017-11-29       Impact factor: 4.181

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.